Cellular Intelligence

formerly Somite

Building a future where biology is design

Boston, United States · Founded 2023 · $57.1M raised

Employees
11–50
Founded
2023
Business Model
B2B
Total Funding
$57.1M
Last Round
$47.0M Series AMay 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Founded in late 2023, Somite AI developed an AI platform called AlphaStem targeting cell therapy and drug development. In 2026 the company rebranded as Cellular Intelligence, building the first universal virtual cell-signaling model to decode and control cellular behavior. Backed by Khosla Ventures, Chan Zuckerberg Initiative, and AMD Ventures, the company has raised over $100M with scientific co-founders from Harvard Medical School and MIT.

Summary

Cellular Intelligence is a Healthcare company based in Boston, United States, founded in 2023. It has raised $57.1M in total across 3 rounds, most recently a $47.0M Series A round in May 2025. Investors include Khosla Ventures, SciFi VC and Chan Zuckerberg Initiative.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2025
$47.0M

Sign up to see all 3 events

Funding: Pre-Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cellular Intelligence on Indexed.vc
<a href="https://indexed.vc/companies/cellular-intelligence"><img src="https://indexed.vc/api/badge/company/cellular-intelligence" alt="Cellular Intelligence on Indexed.vc" width="260" height="76" /></a>